Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Full disclosure: GSK’s pledge to open clinical trial data

Soon after GlaxoSmithKline (GSK) pleaded guilty in the US to withholding safety data from regulators, the global healthcare company has been proactive in restoring its image. But will a pledge to make detailed trial data available be enough to appease its critics? Dr Nicola Davies reports.

Free download worth over $5000
Download our 2018 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global technology, media and telecoms

Go Top